Cytokinetics Inc CYTK

NAS: CYTK | ISIN: US23282W6057 14/11/2024

54,70 USD (-2,25%)

(-2,25%) 14/11/2024

Grafiek Cytokinetics Inc

Grafiek Cytokinetics Inc

1 dag1d -2,25%
1 week1w -5,66%
1 maand1m -1,23%
3 maanden3m -4,14%
6 maanden6m -9,59%
1 jaar1j 66,62%
5 jaar5j 568,70%

Cytokinetics Inc in het nieuws

Toon enkel gratis nieuws

2 maart 2024 · Super Micro Computer and Deckers Outdoor Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 · Persbericht

18 maart 2021 · Cytokinetics Announces Secondary Analysis From GALACTIC-HF to Be Presented in Late Breaking Clinical Trial Session at American College of Cardiology 70th Annual Scientific Session & Expo (ACC.21) · Persbericht

26 februari 2021 · Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

26 februari 2021 · Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day · Persbericht

2 februari 2021 · Cytokinetics Announces Recipients of Third Annual Communications Fellowship Grants · Persbericht

1 februari 2021 · Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

13 januari 2021 · Cytokinetics Announces First Patient Dosed in Cohort 2 of Redwood-HCM · Persbericht

11 januari 2021 · Cytokinetics Granted Orphan Drug Designation for CK-3773274 for the Treatment of Hypertrophic Cardiomyopathy · Persbericht

6 januari 2021 · Cytokinetics to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference · Persbericht

Profiel Cytokinetics Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: cytokinetics.com

Hoofdzetel: South San Francisco, California Verenigde Staten

CEO: Robert Blum

Werknemers: 447

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe